Correlation Between Sinphar Pharmaceutical and Taiwan Takisawa
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Taiwan Takisawa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Taiwan Takisawa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Taiwan Takisawa Technology, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Taiwan Takisawa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Taiwan Takisawa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Taiwan Takisawa.
Diversification Opportunities for Sinphar Pharmaceutical and Taiwan Takisawa
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sinphar and Taiwan is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Taiwan Takisawa Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taiwan Takisawa Tech and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Taiwan Takisawa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taiwan Takisawa Tech has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Taiwan Takisawa go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and Taiwan Takisawa
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the Taiwan Takisawa. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 6.57 times less risky than Taiwan Takisawa. The stock trades about -0.19 of its potential returns per unit of risk. The Taiwan Takisawa Technology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 7,590 in Taiwan Takisawa Technology on September 2, 2024 and sell it today you would earn a total of 720.00 from holding Taiwan Takisawa Technology or generate 9.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sinphar Pharmaceutical Co vs. Taiwan Takisawa Technology
Performance |
Timeline |
Sinphar Pharmaceutical |
Taiwan Takisawa Tech |
Sinphar Pharmaceutical and Taiwan Takisawa Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sinphar Pharmaceutical and Taiwan Takisawa
The main advantage of trading using opposite Sinphar Pharmaceutical and Taiwan Takisawa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Taiwan Takisawa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taiwan Takisawa will offset losses from the drop in Taiwan Takisawa's long position.Sinphar Pharmaceutical vs. Taiwan Semiconductor Manufacturing | Sinphar Pharmaceutical vs. Hon Hai Precision | Sinphar Pharmaceutical vs. MediaTek | Sinphar Pharmaceutical vs. Chunghwa Telecom Co |
Taiwan Takisawa vs. TMP Steel | Taiwan Takisawa vs. Softstar Entertainment | Taiwan Takisawa vs. China Steel Corp | Taiwan Takisawa vs. Mayer Steel Pipe |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Correlations Find global opportunities by holding instruments from different markets |